Trial Phase
Trial Status
Paid Participation
Clear All
38 Lymphoma Trials
Power is an online platform that helps thousands of Lymphoma patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Ibrutinib + Stem Cell Transplant for Lymphoma
Kingman, KansasIbrutinib + Rituximab for Chronic Lymphocytic Leukemia
Kingman, KansasObinutuzumab-Based Therapy for Follicular Lymphoma
Kingman, KansasRituximab + Stem Cell Transplant for Mantle Cell Lymphoma
Kingman, KansasCrizotinib for Non-Small Cell Lung Cancer
Kingman, KansasKey Eligibility Criteria
Rituximab + Chemotherapy +/- Lenalidomide for Lymphoma
Wichita, KansasBrentuximab Vedotin + Nivolumab for Hodgkin's Lymphoma
Wichita, KansasKey Eligibility Criteria
Epcoritamab + Lenalidomide for B-Cell Lymphoma
Wichita, KansasKey Eligibility Criteria
Epcoritamab + R-CHOP for Diffuse Large B-Cell Lymphoma
Wichita, KansasJCAR017 for Non-Hodgkin's Lymphoma
Wichita, KansasKey Eligibility Criteria
Nivolumab + Chemo-Immunotherapy for Large B-Cell Lymphoma
Wichita, KansasKey Eligibility Criteria
Combination Therapy for Chronic Lymphocytic Leukemia
Wichita, KansasCombination Therapy for Mantle Cell Lymphoma
Wichita, KansasInotuzumab Ozogamicin for Acute Lymphoblastic Leukemia
Wichita, KansasKey Eligibility Criteria
JCAR017 for Chronic Leukemia or Lymphoma
Wichita, KansasKey Eligibility Criteria
Glofitamab + Pola-R-CHP for B-Cell Lymphoma
Wichita, KansasKey Eligibility Criteria
Tafasitamab + Lenalidomide for Diffuse Large B-Cell Lymphoma
Wichita, KansasZanubrutinib + Anti-CD20 for Lymphoma
Wichita, KansasKey Eligibility Criteria
Acalabrutinib + R-CHOP for Diffuse Large B-Cell Lymphoma
Wichita, KansasImmunotherapy + Chemotherapy for Hodgkin's Lymphoma
Great Bend, KansasVenetoclax + Chemotherapy for B-Cell Lymphoma
Great Bend, KansasVenetoclax + Vincristine for Acute Lymphoblastic Leukemia
Great Bend, KansasTargeted Therapy for Cancer
Great Bend, KansasChemotherapy Combinations for Mantle Cell Lymphoma
Great Bend, KansasFrequently Asked Questions
How much do Lymphoma clinical trials pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do Lymphoma clinical trials work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Lymphoma trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for Lymphoma is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a Lymphoma medical study ?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest Lymphoma clinical trials ?
Most recently, we added UBX-303061 for Cancer, Rituximab vs Mosunetuzumab for Follicular Lymphoma and Epcoritamab + Lenalidomide for B-Cell Lymphoma to the Power online platform.